De Rekeneire Nathalie, Resnick Helaine E, Schwartz Ann V, Shorr Ronald I, Kuller Lewis H, Simonsick Eleanor M, Vellas Bruno, Harris Tamara B
Laboratory of Epidemiology, Demography and Biometry, National Institute on Aging, Bethesda, Maryland, USA.
Diabetes Care. 2003 Dec;26(12):3257-63. doi: 10.2337/diacare.26.12.3257.
The aim of this study was to examine the role of comorbid conditions and body composition in the association between diabetes and subclinical functional limitation, an indication of early functional decline, in well-functioning older individuals.
This was a cross-sectional analysis of 3,075 well-functioning black and white men and women aged 70-79 years, enrolled in the Health, Aging, and Body Composition study. Diabetes was defined by self-report and/or hypoglycemic medication use or fasting glucose >/=126 mg/dl. Subclinical functional limitation was defined using self-report of capacity and objective performance measures. Comorbid conditions were identified by self-reported diagnoses, medication use, and clinical measures. Body composition measures included anthropometry and total fat (dual X-ray absorptiometry).
Of 2,926 participants, 1,252 (42.8%) had subclinical functional limitation at baseline. Among 2,370 individuals without diabetes, 40% had subclinical functional limitation, whereas the prevalence was 53% among the 556 diabetic participants with an age/sex/race-adjusted odds ratio (OR) 1.70 (95% CI 1.40-2.06). This association remained significant when adjusted for body composition measures (OR 1.54 [1.26-1.88]), diabetes-related comorbidities, and other potential confounders (OR 1.40 [1.14-1.73]). In the fully adjusted model, consideration of HbA(1c) (< or >/=7%) and diabetes duration showed that poor glycemic control in diabetic individuals explained the association with subclinical functional limitation.
In a well-functioning older population, diabetes is associated with early indicators of functional decline, even after accounting for body composition and diabetes-related comorbidities. Poor glycemic control contributes to this relationship. Whether improvement in glycemic control in older people with diabetes would change this association should be tested.
本研究旨在探讨合并症和身体成分在糖尿病与亚临床功能受限(早期功能衰退的一个指标)之间的关联中的作用,研究对象为功能良好的老年人。
这是一项对3075名年龄在70 - 79岁、功能良好的黑人和白人男性及女性进行的横断面分析,这些人参与了健康、衰老与身体成分研究。糖尿病通过自我报告和/或使用降糖药物或空腹血糖≥126mg/dl来定义。亚临床功能受限通过能力的自我报告和客观表现测量来定义。合并症通过自我报告的诊断、药物使用和临床测量来确定。身体成分测量包括人体测量和总脂肪量(双能X线吸收法)。
在2926名参与者中,1252名(42.8%)在基线时存在亚临床功能受限。在2370名无糖尿病的个体中,40%存在亚临床功能受限,而在556名糖尿病参与者中,这一患病率为53%,年龄/性别/种族调整后的比值比(OR)为1.70(95%CI 1.40 - 2.06)。在对身体成分测量、糖尿病相关合并症和其他潜在混杂因素进行调整后,这种关联仍然显著(OR 1.54 [1.26 - 1.88])。在完全调整模型中,考虑糖化血红蛋白(HbA1c)(<或≥7%)和糖尿病病程显示,糖尿病患者血糖控制不佳解释了与亚临床功能受限的关联。
在功能良好的老年人群中,即使考虑了身体成分和糖尿病相关合并症,糖尿病仍与功能衰退的早期指标相关。血糖控制不佳促成了这种关系。糖尿病老年人血糖控制的改善是否会改变这种关联有待检验。